As far as we are aware, our research marks the initial study to clarify the tumor-promoting function of ALDH18A1 (P5CS) in ccRCC, indicating its potential as a therapeutic target for this disease. The gene discussed is ALDH18A1; the disease is nonpapillary renal cell carcinoma.